Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Exposure of BL-7010 in Celiac Disease
NCT01990885Phase 2Completed
- Sponsor
- BioLineRx Ltd.
- Start
- Dec 2013
- Primary completion
- Oct 2014
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of BL-7010 in celiac disease, sponsored by BioLineRx Ltd.. Started Dec 2013; status: completed.
02
Drugs
BL-7010
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT01990885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01990885.